There were 2,200 press releases posted in the last 24 hours and 438,156 in the last 365 days.

Rodriguez To Take Over As Clarient CFO

December 3, 2009 (FinancialWire) — Clarient, Inc. (NASDAQ: CLRT) has launched a CFO transition plan that calls for financial executive Michael R. Rodriguez to become its senior vice president and chief financial officer on December 7.

Raymond J. Land, the current senior vice president and chief financial officer of Clarient, will continue to serve in that position until Rodriguez takes over Land’s duties, after which Land will remain with Clarient as a consultant until the final fiscal 2009 accounting is completed and Clarient’s form 10-K is filed with the Securities and Exchange Commission.

Rodriguez has served as a senior financial executive in a variety of emerging growth companies. His most recent experience was as chief financial officer of Irvine, California-based Endocare, a medical device company focused on minimally invasive technologies for tissue and tumor ablation, from 2004 through July 2009, when it was acquired by HealthTronics.

California-based Clarient’s principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The company provides oncology diagnostic technologies, such as flow cytometry and molecular testing.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports, filings and conference call webcasts for companies mentioned in the news are available via Investrend Syndications (http://investrend.ar.wilink.com/?level=279). The most recently issued reports and/or recorded webcasts include Cascade Corp. (NYSE: CASC), Anadarko Petroleum Corp. (NYSE: APC), Baytex Energy Trust (NYSE: BTE) (TSX: BTE), H & Q Healthcare Investors (NYSE: HQH), H & Q Life Science Investors (NYSE: HQL), PIMCO (NYSE: PYN) (NYSE: PMX) (NYSE: PZC), PIMCO Global StocksPLUS & Income Fund (NYSE: PGP), Taiwan Greater China Fund (NYSE: TFC) and Wolseley PLC (OTC: WOSCF) (London Stock Exchange: WOS).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.